The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
- Conditions
- Hemophilia AHemophilia B
- Interventions
- Behavioral: CounselingBehavioral: Control
- Registration Number
- NCT00212459
- Lead Sponsor
- New York Presbyterian Hospital
- Brief Summary
The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.
- Detailed Description
The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.To do this subjects will be randomized into a control group and a group who will receive consistent counselling by a pharmacist about their bleeding logs.
The aims of the study are:
* To provide a new method of bleeding and treatment documentation in the home setting (logs) to adolescent subjects with Hemophilia A or B
* To counsel these subjects about adherence to their treatment regimen prescribed by physician and the importance of keeping accurate documentation of each bleeding episode and its treatment.
* To improve maintenance of logs, to allow for 1) assessment of bleeding frequency and treatment efficacy and 2) early detection of target joint bleeding and the potential need for prophylactic factor replacement.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 14
- Ages 12 through 20
- Severe or moderate Hemophilia A or B
- Self-infusing or transitioning to self infusion in the home setting
- Already assigned responsibility of monitoring bleeding logs
- Not meeting inclusion criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Counseling Patients are contacted every two weeks after initial counseling to discuss completion of bleeding records. 2 Control After the initial counseling with regards to bleeding records, there are no more contacts made with the control patients.
- Primary Outcome Measures
Name Time Method Study and control groups will be compared with respect to the % of bleeds reported to the HTC and % of recommended therapy recorded in bleeding logs after a 6 month period 6 months
- Secondary Outcome Measures
Name Time Method Study and control groups will be compared with respect to time between initiation of target joint bleeding and the identification and treatment of such by HTC personnel 6 months Clotting factor consumption and the cost of therapy in each group will be compared 6 months
Trial Locations
- Locations (1)
NY Presbyterian Hospital
🇺🇸New York, New York, United States